• 2760 Citations
  • 24 h-Index
1989 …2018
If you made any changes in Pure these will be visible here soon.

Research Output 1989 2018

  • 2760 Citations
  • 24 h-Index
  • 110 Article
  • 1 Letter
  • 1 Review article
Filter
Article
2018

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial

on behalf of the TOSCA Investigators, May 20 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin
oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Investigators, O. B. O. T. TOSCA., Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S. & 2 others, Rulli, E. & Labianca, R., May 20 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial

Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S., Rulli, E. & 1 others, Labianca, R., 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial

Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S., Rulli, E. & 1 others, Labianca, R., 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin

FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Investigators, TOSCA., Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S. & 2 others, Rulli, E. & Labianca, R., May 20 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin
Anus Neoplasms
Squamous Cell Neoplasms
Radiotherapy
Recurrence
Vagina

Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis

Zabaleta, J., Iida, T., Falcoz, P. E., Salah, S., Jarabo, J. R., Correa, A. M., Zampino, M. G., Matsui, T., Cho, S., Ardissone, F., Watanabe, K., Gonzalez, M., Gervaz, P., Emparanza, J. I. & Abraira, V., Jul 1 2018, In : European Journal of Surgical Oncology. 44, 7, p. 1006-1012 7 p.

Research output: Contribution to journalArticle

Metastasectomy
Meta-Analysis
Colorectal Neoplasms
Neoplasm Metastasis
Lung

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

Pinto, C., Normanno, N., Orlandi, A., Fenizia, F., Damato, A., Maiello, E., Tamburini, E., Di Costanzo, F., Tonini, G., Bilancia, D., Corsi, D., Pisconti, S., Ferrau, F., Gori, S., Daniele, B., Zaniboni, A., Soto Parra, H., Frassinetti, G. L., Iaffaioli, R. V., Cassata, A. & 4 others, Zampino, M. G., Repetto, L., Calegari, M. A. & Barone, C., 2018, In : Future Oncology. 14, 14, p. 1339-1346 8 p.

Research output: Contribution to journalArticle

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

Pinto, C., Normanno, N., Orlandi, A., Fenizia, F., Damato, A., Maiello, E., Tamburini, E., Di Costanzo, F., Tonini, G., Bilancia, D., Corsi, D., Pisconti, S., Ferrau, F., Gori, S., Daniele, B., Zaniboni, A., Soto Parra, H., Frassineti, G. L. P., Iaffaioli, R. V., Cassata, A. & 4 others, Zampino, M. G., Repetto, L., Calegari, M. A. & Barone, C., 2018, In : Future Oncology. 14, 14, p. 1339-1346 8 p.

Research output: Contribution to journalArticle

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

Pinto, C., Normanno, N., Orlandi, A., Fenizia, F., Damato, A., Maiello, E., Tamburini, E., Di Costanzo, F., Tonini, G., Bilancia, D., Corsi, D., Pisconti, S., Ferrau, F., Gori, S., Daniele, B., Zaniboni, A., Soto Parra, H., Frassinetti, G. L., Iaffaioli, R. V., Cassata, A. & 4 others, Zampino, M. G., Repetto, L., Calegari, M. A. & Barone, C., 2018, In : Future Oncology. 14, 14, p. 1339-1346 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Therapeutics
Anti-Idiotypic Antibodies
Quality of Life
Medicine

Phase III study with FOLFIRI plus cetuximab versus FOLFIRI plus cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

Pinto, C., Normanno, N., Orlandi, A., Fenizia, F., Damato, A., Maiello, E., Tamburini, E., Di Costanzo, F., Tonini, G., Bilancia, D., Corsi, D., Pisconti, S., Ferrau, F., Gori, S., Daniele, B., Zaniboni, A., Parra, H. S., Frassinetti, G. L., Iaffaioli, R. V., Cassata, A. & 4 others, Zampino, M. G., Repetto, L., Calegari, M. A. & Barone, C., Jun 1 2018, In : Future Oncology. 14, 14, p. 1339-1346 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Therapeutics
Anti-Idiotypic Antibodies
Quality of Life
Drug Therapy
irinotecan
Particle Size
Neoplasm Metastasis
Liver
Disease-Free Survival
2017

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial

Giampieri, R., Puzzoni, M., Daniele, B., Ferrari, D., Lonardi, S., Zaniboni, A., Cavanna, L., Rosati, G., Pella, N., Zampino, M. G., Sozzi, P., Germano, D., Zagonel, V., Codecà, C., Libertini, M., Labianca, R., Cascinu, S., Scartozzi, M. & The Italian Group for the Study of Gastrointestinal Cancer (GISCAD), Oct 10 2017, In : British Journal of Cancer. 117, 8, p. 1099-1104 6 p.

Research output: Contribution to journalArticle

Gastrointestinal Tract
Colorectal Neoplasms
Oxidoreductases
Milk
Serum

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial

Giampieri, R., Puzzoni, M., Daniele, B., Ferrari, D., Lonardi, S., Zaniboni, A., Cavanna, L., Rosati, G., Pella, N., Zampino, M. G., Sozzi, P., Germano, D., Zagonel, V., Codecà, C., Libertini, M., Labianca, R., Cascinu, S. & Scartozzi, M., 2017, In : British Journal of Cancer. 117, 8, p. 1099-1104 6 p.

Research output: Contribution to journalArticle

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Massida, B., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E. & 3 others, Rulli, E., Labianca, R. & TOSCA (Three or Six Colon Adjuvant) Investigators, Feb 23 2017, In : Annals of Oncology.

Research output: Contribution to journalArticle

2016

Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?

Chiappa, A., Bertani, E., Zbar, A. P., Foschi, D., Fazio, N., Zampino, M. G., Belluco, C., Orsi, F., Della Vigna, P., Bonomo, G., Venturino, M., Ferrari, C. & Biffi, R., Mar 1 2016, In : International Journal of Oncology. 48, 3, p. 1280-1289 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Neoplasm Metastasis
Liver
Colorectal Surgery
Therapeutics

Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?

Chiappa, A., Bertani, E., Zbar, A. P., Foschi, D., Fazio, N., Zampino, M. G., Belluco, C., Orsi, F., Della Vigna, P., Bonomo, G., Venturino, M., Ferrari, C. & Biffi, R., Mar 1 2016, In : International Journal of Oncology. 48, 3, p. 1280-1289 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Neoplasm Metastasis
Liver
Colorectal Surgery
Therapeutics

Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?

Chiappa, A., Bertani, E., Zbar, A. P., Foschi, D., Fazio, N., Zampino, M., Belluco, C., Orsi, F., Vigna, P. D., Bonomo, G., Venturino, M., Ferrari, C. & Biffi, R., Mar 1 2016, In : International Journal of Oncology. 48, 3, p. 1280-1289 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Neoplasm Metastasis
Liver
Colorectal Surgery
Therapeutics
Chemoradiotherapy
Rectal Neoplasms
Fluorodeoxyglucose F18
Neoadjuvant Therapy
Tumor Burden

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 2 others, Labianca, R. & Investigators, TOSCA. T. O. S. C. A., Nov 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
oxaliplatin
Therapeutics
Adjuvant Chemotherapy
XELOX

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 2 others, Labianca, R. & TOSCA (Three or Six Colon Adjuvant) Investigators, Nov 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Compliance
Safety
oxaliplatin
Therapeutics

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 1 others, Labianca, R., 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Compliance
Safety
oxaliplatin
Therapeutics

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 1 others, Labianca, R., 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 1 others, Labianca, R., 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Preoperative versus postoperative docetaxel-cisplatin- fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial

Fazio, N., Biffi, R., Maibach, R., Hayoz, S., Thierstein, S., Brauchli, P., Bernhard, J., Stupp, R., Andreoni, B., Renne, G., Crosta, C., Morant, R., Chiappa, A., Luca, F., Zampino, M. G., Huber, O., Goldhirsch, A., De Braud, F., Roth, A., Pace, U. & 15 others, Cenciarelli, S., Pozzi, S., Bertani, E., Mura, S., Lorizzo, K., Di Meglio, G., Ravizza, D., Boselli, S., Matter, M., Richter, M., Monfardini, S., Dittrich, C., Häfner, M., Clemens, M. & Crowe, S., Apr 1 2016, In : Annals of Oncology. 27, 4, p. 668-673 6 p., mdv620.

Research output: Contribution to journalArticle

docetaxel
Fluorouracil
Cisplatin
Stomach
Carcinoma

Preoperative versus postoperative docetaxel-cisplatin- fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial

Fazio, N., Biffi, R., Maibach, R., Hayoz, S., Thierstein, S., Brauchli, P., Bernhard, J., Stupp, R., Andreoni, B., Renne, G., Crosta, C., Morant, R., Chiappa, A., Luca, F., Zampino, M. G., Huber, O., Goldhirsch, A., de Braud, F., Roth, A. D., Pace, U. & 15 others, Cenciarelli, S., Pozzi, S., Bertani, E., Mura, S., Lorizzo, K., Di Meglio, G., Ravizza, D., Boselli, S., Matter, M., Richter, M., Monfardini, S., Dittrich, C., Häfner, M., Clemens, M. & Crowe, S., Apr 1 2016, In : Annals of Oncology. 27, 4, p. 668-673 6 p., mdv620.

Research output: Contribution to journalArticle

docetaxel
Fluorouracil
Cisplatin
Stomach
Carcinoma
irinotecan
Stomach Neoplasms
Randomized Controlled Trials
Taxoids
Biological Therapy

The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death

Pozzi, C., Cuomo, A., Spadoni, I., Magni, E., Silvola, A., Conte, A., Sigismund, S., Ravenda, P. S., Bonaldi, T., Zampino, M. G., Cancelliere, C., Di Fiore, P. P., Bardelli, A., Penna, G. & Rescigno, M., 2016, In : Nature Medicine.

Research output: Contribution to journalArticle

Chemotherapy
Cell death
Epidermal Growth Factor Receptor
Cell Death
Drug Therapy

The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death

Pozzi, C., Cuomo, A., Spadoni, I., Magni, E., Silvola, A., Conte, A., Sigismund, S., Ravenda, P. S., Bonaldi, T., Zampino, M. G., Cancelliere, C., Di Fiore, P. P., Bardelli, A., Penna, G. & Rescigno, M., May 2 2016, (Accepted/In press) In : Nature Medicine.

Research output: Contribution to journalArticle

Chemotherapy
Cell death
Epidermal Growth Factor Receptor
Cell Death
Drug Therapy
2015

Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: From bench to bedside

Cella, C. A., Minucci, S., Spada, F., Galdy, S., Elgendy, M., Ravenda, P. S., Zampino, M. G., Murgioni, S. & Fazio, N., Nov 1 2015, In : Cancer Treatment Reviews. 41, 9, p. 754-760 7 p.

Research output: Contribution to journalArticle

Sirolimus
Vascular Endothelial Growth Factor A
Neoplasms
Biomarkers
Cell Proliferation
Anus Neoplasms
Squamous Cell Carcinoma
Papillomavirus Infections
Radiation Tolerance
Chemoradiotherapy
2014

Brain metastases from colorectal cancer: Main clinical factors conditioning outcome

Magni, E., Santoro, L., Ravenda, P. S., Leonardi, M. C., Bonomo, G., Monfardini, L., Nolè, F. & Zampino, M. G., Feb 2014, In : International Journal of Colorectal Disease. 29, 2, p. 201-208 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Neoplasm Metastasis
Brain
Survival
Drug Therapy
Cost-Benefit Analysis
Costs and Cost Analysis
Subclavian Vein
Head
Jugular Veins
Circulating Neoplastic Cells
Neoadjuvant Therapy
Rectal Neoplasms
Disease-Free Survival
Chemoradiotherapy
Colorectal Neoplasms
Neoplasm Metastasis
Lung
Carcinoembryonic Antigen
Confidence Intervals

Prognostic value of human papillomavirus in anal squamous cell carcinoma

Ravenda, P. S., Magni, E., Botteri, E., Manzotti, M., Barberis, M., Vacirca, D., Trovato, C. M., Dell'Acqua, V., Leonardi, M. C., Sideri, M., Fazio, N. & Zampino, M. G., 2014, In : Cancer Chemotherapy and Pharmacology. 74, 5, p. 1033-1038 6 p.

Research output: Contribution to journalArticle

Squamous Cell Carcinoma
Anus Neoplasms
Chemoradiotherapy
Disease-Free Survival
Polymerase chain reaction
2013
Colonic Neoplasms
Adjuvant Chemotherapy
Colon
Lymph Nodes
Incidence
2012
Hot Temperature
Liver
Neoplasms
Therapeutics
Safety
Colonic Neoplasms
Adjuvant Chemotherapy
Colon
Lymph Nodes
Incidence
2011
Autoimmunity
Breast Neoplasms
Autoimmune Diseases
Immune System Diseases
Immune System
Fluorouracil
Cisplatin
Squamous Cell Carcinoma
Radiotherapy
Anus Neoplasms

No impact of central venous insertion site on oncology patients' quality of life and psychological distress. A randomized three-arm trial

Biffi, R., Orsi, F., Pozzi, S., Maldifassi, A., Radice, D., Rotmensz, N., Zampino, M. G., Fazio, N., Peruzzotti, G. & Didier, F., Oct 2011, In : Supportive Care in Cancer. 19, 10, p. 1573-1580 8 p.

Research output: Contribution to journalArticle

Quality of Life
Psychology
Veins
Neck
Head

Trattamento chirurgico del cancro del retto con tecnica robotica: risultati a breve termine di uno studio prospettico monocentrico

Translated title of the contribution: Robotic rectal resection in rectal cancer: Short term results in an monocentric prospective studyBianchi, P. P., Petz, W., Spinoglio, G., Belotti, D., Bertani, E., Zampino, M. G., Crosta, C., Lazzari, R. & Andreoni, B., Dec 2011, In : Minerva Chirurgica. 66, 6, p. 527-535 9 p.

Research output: Contribution to journalArticle

Robotics
Rectal Neoplasms
Prospective Studies
Drug Therapy
Transverse Colon
Neoplasms
Boredom
Psychology
Music Therapy
Psychological Stress
2010

Aggressive Treatment Approach for Cloacogenic Carcinoma of the Anorectum: Report from a Single Cancer Center

Bertani, E., Chiappa, A., Mazzarol, G., Contino, G., Lazzari, R., Zampino, M. G., Viale, G. & Andreoni, B., Jul 31 2010, (Accepted/In press) In : Digestive Surgery. 27, 4, p. 297-301 5 p.

Research output: Contribution to journalArticle

Anus Neoplasms
Neoplasms
Mitomycin
Therapeutics
Standard of Care

High-intensity focused ultrasound effect in breast cancer nodal metastasis

Orgera, G., Curigliano, G., Krokidis, M., Bonomo, G., Monfardini, L., Della Vigna, P., Zampino, M. G. & Orsi, F., Apr 2010, In : CardioVascular and Interventional Radiology. 33, 2, p. 447-449 3 p.

Research output: Contribution to journalArticle

In Reply to Drs. Mutahir and Hashmi

Zampino, M. G., Magni, E., Leonardi, M. C. & Luca, F., Mar 15 2010, In : International Journal of Radiation Oncology Biology Physics. 76, 4, p. 1275-1276 2 p.

Research output: Contribution to journalArticle

Primary pure gastric yolk sac tumor

Magni, E., Sonzogni, A. & Zampino, M. G., 2010, In : Rare Tumors. 2, 1, p. 31-33 3 p.

Research output: Contribution to journalArticle

Endodermal Sinus Tumor
Stomach
Gastrectomy
Deglutition Disorders
Gastric Mucosa
Robotics
Rectal Neoplasms
Safety
Anastomotic Leak
Chemoradiotherapy